We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.
SAN MATEO, Calif. and CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today...
Phase 1/2 study of KB-0742 is on track to clear 80mg four-days-on, three-days-off schedule in the third quarter of 2024; topline data from expansion cohort at this schedule expected in the first...
Company to assess KB-0742 at planned new dose schedule in ongoing phase 1/2 study; topline data from expansion cohort at new dose schedule expected in the first half of 2025 IND-enabling studies...
SAN MATEO, Calif. and CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today...
SAN MATEO, Calif. and CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to transforming the lives of those affected by cancer, today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.07 | -6.79611650485 | 1.03 | 1.07 | 0.9 | 1141771 | 0.95607419 | CS |
4 | -0.3 | -23.8095238095 | 1.26 | 1.38 | 0.9 | 453660 | 1.03638416 | CS |
12 | -0.19 | -16.5217391304 | 1.15 | 1.4 | 0.9 | 376630 | 1.09704969 | CS |
26 | 0.08 | 9.09090909091 | 0.88 | 1.5053 | 0.731 | 289130 | 1.09594271 | CS |
52 | -0.34 | -26.1538461538 | 1.3 | 2.29 | 0.731 | 283177 | 1.32321897 | CS |
156 | -22.37 | -95.8851264466 | 23.33 | 28.42 | 0.731 | 292764 | 6.56028556 | CS |
260 | -27.33 | -96.6065747614 | 28.29 | 39.605 | 0.731 | 283787 | 9.47348477 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions